Earnings season is revving up, and a fresh batch of companies are lined up to report their quarterly results next week. As savvy investors know, earnings announcements can trigger major stock movements - both positive and negative - depending on how the numbers stack up against Wall Street's expectations.
If a firm exceeds forecasted earnings per share (EPS), it often translates into an upward surge in the share price as the market reacts favorably. Conversely, failing to meet EPS projections frequently leads to a sell-off as investors reassess the company's outlook.
With that pivotal backdrop in mind, here are eight stocks primed for potentially volatile moves when they unveil their latest earnings figures in the trading days ahead. This diverse group spans sectors like pharmaceuticals, industrials, software and consumer goods - each offering a unique risk/reward profile to evaluate:
Alpine 4 Holdings (ALPP) - This acquisition-focused manufacturing and construction services company is scheduled to report on July 10th. Analysts are bullish on ALPP, rating it a "buy" with significant upside from its recent $0.49 price. Can ALPP beat the projected $-0.15 EPS?
US Citizens Spied on Before Election
Just months before the election…⬅️⬅️ Joe Biden's administration is rolling out Rule 613…
A mass US citizen surveillance program.
Your most personal and private data will now be seen and collected.
You do NOT have much time…
Click here to see what to do.
Oramed Pharmaceuticals (ORMP) - The $109 million biotech focused on oral insulin and other protein therapies steps into the earnings confessional on July 10th. Holding a "hold" rating currently, ORMP has an opportunity to impress if beating the $0.02 EPS forecast from its $2.68 base.
Nurix Therapeutics (NRIX) - This $1.3 billion biotech specializing in protein modulation therapies reports the same day. Analysts recommend NRIX as a "buy" ahead of the $-0.80 EPS consensus, with shares trading around $20.74. Positive trial data could catalyze a rally.
AngioDynamics (ANGO) - Analysts are split on this $238 million medical device maker reporting Q4 results next Tuesday. Its recent $5.93 price looks cheap if ANGO can top the projected $-0.14 EPS loss, but further misses could add to selling pressure.
WD-40 Company (WDFC) - The $3 billion household products icon behind its namesake lubricant and cleaning lines gets put to the test on July 10th. A "buy" rated stock at $221, but a miss on the $1.11 EPS estimate could deflate WDFC's premium valuation.
AZZ Inc. (AZZ) - This $2.3 billion provider of metal coatings, energy solutions and other industrial services reports the same day. AZZ's forecast of $0.70 EPS has it rated a "buy" around $77 - however, any guidance cuts may undermine the bull case.
Loop Industries (LOOP) - A pioneer in sustainable plastic recycling technology, the $101 million LOOP steps up to the earnings plate on July 10th. Analysts are bullish, but an expected $-0.10 EPS loss highlights its developmental stage. Execution updates could move the needle.
E2open Parent Holdings (ETWO) - Rounding out our watchlist, this $1.3 billion supply chain software firm announces earnings results next Tuesday. While only rated a "hold" for now, beating the Street's $0.044 EPS view may buoy the $4.30 share price.
As you can see, we've got a smorgasbord of opportunities (and risks) across various sectors and market caps. Some bullish analysts are already pounding the table, while others have cooler heads prevailing amid the economic crosscurrents.
Earnings periods often catalyze big stock swings, so make sure you've done your homework if you plan on trading any of these event-driven situations. Armed with the fundamental forecasts, you can determine which potential movers and shakers deserve a spot in your portfolio's earnings season watchlist.
